Daming Changda

Changzhou Daming Changda Biotechnology is a technology-driven enterprise specializing in biocatalysis and enzyme engineering for the production of high-value pharmaceutical intermediates. Founded in 2008 and closely affiliated with Changzhou University, the company focuses on the development of green manufacturing processes for chiral compounds, including non-natural amino acids and chiral alcohols. Daming Changda operates a robust platform for enzyme screening, directed evolution, and industrial-scale fermentation, providing sustainable alternatives to traditional chemical synthesis. Its products, such as D-tert-leucine, are critical components in the synthesis of major antiviral and antidiabetic medications. The company serves a global clientele, offering both catalog products and custom synthesis services to the pharmaceutical and fine chemical sectors.